1-[(2S)-1-methylpiperidin-2-yl]propan-2-one

Details

Top
Internal ID 3ddfdc24-1cc3-4995-b572-0bef88ab62e0
Taxonomy Organoheterocyclic compounds > Piperidines
IUPAC Name 1-[(2S)-1-methylpiperidin-2-yl]propan-2-one
SMILES (Canonical) CC(=O)CC1CCCCN1C
SMILES (Isomeric) CC(=O)C[C@@H]1CCCCN1C
InChI InChI=1S/C9H17NO/c1-8(11)7-9-5-3-4-6-10(9)2/h9H,3-7H2,1-2H3/t9-/m0/s1
InChI Key TYHJMEIBGDDCPA-VIFPVBQESA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C9H17NO
Molecular Weight 155.24 g/mol
Exact Mass 155.131014166 g/mol
Topological Polar Surface Area (TPSA) 20.30 Ų
XlogP 0.80
Atomic LogP (AlogP) 1.45
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 2

Synonyms

Top
SCHEMBL21462061

2D Structure

Top
2D Structure of 1-[(2S)-1-methylpiperidin-2-yl]propan-2-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9463 94.63%
Caco-2 + 0.9216 92.16%
Blood Brain Barrier + 0.9250 92.50%
Human oral bioavailability - 0.6143 61.43%
Subcellular localzation Mitochondria 0.6428 64.28%
OATP2B1 inhibitior - 0.8357 83.57%
OATP1B1 inhibitior + 0.9593 95.93%
OATP1B3 inhibitior + 0.9469 94.69%
MATE1 inhibitior - 0.8400 84.00%
OCT2 inhibitior + 0.6500 65.00%
BSEP inhibitior - 0.9332 93.32%
P-glycoprotein inhibitior - 0.9804 98.04%
P-glycoprotein substrate - 0.7883 78.83%
CYP3A4 substrate - 0.5996 59.96%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate + 0.5193 51.93%
CYP3A4 inhibition - 0.9891 98.91%
CYP2C9 inhibition - 0.9341 93.41%
CYP2C19 inhibition - 0.8344 83.44%
CYP2D6 inhibition - 0.9207 92.07%
CYP1A2 inhibition - 0.6191 61.91%
CYP2C8 inhibition - 0.9957 99.57%
CYP inhibitory promiscuity - 0.9849 98.49%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9200 92.00%
Carcinogenicity (trinary) Non-required 0.7044 70.44%
Eye corrosion - 0.8743 87.43%
Eye irritation + 0.8588 85.88%
Skin irritation + 0.5465 54.65%
Skin corrosion + 0.6677 66.77%
Ames mutagenesis - 0.7500 75.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6199 61.99%
Micronuclear - 0.8600 86.00%
Hepatotoxicity + 0.5161 51.61%
skin sensitisation - 0.8405 84.05%
Respiratory toxicity + 0.6111 61.11%
Reproductive toxicity - 0.5889 58.89%
Mitochondrial toxicity + 0.7000 70.00%
Nephrotoxicity - 0.8027 80.27%
Acute Oral Toxicity (c) III 0.7993 79.93%
Estrogen receptor binding - 0.9391 93.91%
Androgen receptor binding - 0.8787 87.87%
Thyroid receptor binding - 0.8607 86.07%
Glucocorticoid receptor binding - 0.8732 87.32%
Aromatase binding - 0.7775 77.75%
PPAR gamma - 0.9235 92.35%
Honey bee toxicity - 0.9669 96.69%
Biodegradation + 0.7500 75.00%
Crustacea aquatic toxicity - 0.6500 65.00%
Fish aquatic toxicity - 0.8591 85.91%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.46% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 94.56% 97.25%
CHEMBL2581 P07339 Cathepsin D 91.75% 98.95%
CHEMBL4040 P28482 MAP kinase ERK2 88.78% 83.82%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 88.72% 93.04%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 84.67% 95.50%
CHEMBL4072 P07858 Cathepsin B 83.22% 93.67%
CHEMBL1795139 Q8IU80 Transmembrane protease serine 6 81.87% 98.33%
CHEMBL5203 P33316 dUTP pyrophosphatase 81.60% 99.18%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 80.64% 95.56%

Cross-Links

Top
PubChem 820378
NPASS NPC181823
LOTUS LTS0073065
wikiData Q105267328